glp-1 vs gip-1 Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1 Glucose-dependent insulinotropic polypeptide receptor signaling

On the immune front, gut microbiota can increase systemic inflammation by releasing lipopolysaccharides (LPS) and proinflammatory cytokines, and they also produce amyloids, which may stimulate neural amyloid production via immune priming

Glucagon-like peptide-1 receptor agonists and gastrointestinal adverse events: a systematic review and meta-analysis

Elevated phenolic content contributes significantly to positive consumer perception, as such bioactive compounds are commonly associated with protective health benefits

Serum il-23 significantly decreased in obese patients with psoriatic arthritis six months after a structured weight loss intervention